Motley Fool Asset Management LLC Has $3.48 Million Stake in GE HealthCare Technologies Inc. $GEHC

Motley Fool Asset Management LLC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 34.4% during the fourth quarter, HoldingsChannel reports. The firm owned 42,370 shares of the company’s stock after acquiring an additional 10,854 shares during the quarter. Motley Fool Asset Management LLC’s holdings in GE HealthCare Technologies were worth $3,475,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Laurel Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $26,000. Optima Capital LLC acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $27,000. Godfrey Financial Associates Inc. acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $27,000. Montag A & Associates Inc. raised its position in shares of GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares during the period. Finally, Maseco LLP acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $29,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on GEHC shares. Rothschild & Co Redburn dropped their price target on GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. BTIG Research dropped their price target on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Evercore set a $80.00 price target on GE HealthCare Technologies in a research report on Thursday, April 30th. JPMorgan Chase & Co. dropped their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. Finally, Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Nine research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.21.

Insiders Place Their Bets

In other news, Director Watkin Phoebe L. Yang bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The shares were acquired at an average price of $63.01 per share, with a total value of $63,010.00. Following the transaction, the director owned 13,702 shares in the company, valued at $863,363.02. This represents a 7.87% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Peter J. Arduini purchased 4,169 shares of the stock in a transaction on Thursday, April 30th. The shares were bought at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the transaction, the chief executive officer directly owned 259,424 shares in the company, valued at approximately $15,544,686.08. The trade was a 1.63% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have acquired 21,847 shares of company stock worth $1,361,355 in the last 90 days. Company insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Down 3.4%

Shares of GE HealthCare Technologies stock opened at $63.76 on Thursday. The business’s 50 day simple moving average is $66.59 and its 200 day simple moving average is $75.36. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The firm has a market cap of $29.00 billion, a PE ratio of 15.25, a P/E/G ratio of 1.49 and a beta of 0.74. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same period in the prior year, the business posted $1.01 EPS. The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.